CommentaryGains and losses from dexamethasone for neonatal chronic lung disease
References (20)
- et al.
Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birthweight infant
J Pediatr
(1995) Dexamethasone therapy in neonatal chronic lung disease: an international, placebo-controlled trial
Pediatrics
(1991)- et al.
Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome
Arch Dis Child
(1996) - et al.
A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant treated infants
Pediatrics
(1996) - et al.
Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicentre clinical trial
Pediatrics
(1997) - et al.
Meta-analysis: a method for synthesising research
Clin Pharmacol Ther
(1995) Corticosteroids and neonatal chronic lung disease
Eur J Pediatr
(1998)- et al.
Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease
Arch Dis Child
(1998) - et al.
Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome
Pediatr Res
(1994) - et al.
Efficacy of sequential early systematic and inhaled corticosteroid therapy in the prevention of chronic lung disease on prematurity
Acta Pediatr
(1998)
There are more references available in the full text version of this article.
Cited by (18)
Neonatal ventilation strategies and long-term respiratory outcomes
2014, Early Human DevelopmentCitation Excerpt :This can lead to asynchrony, active expiration and air leaks [23]. Asynchrony and air leaks can be reduced by the administration of neuromuscular blocking agents [24], but then higher peak pressures are required and infants can become oedematous. An alternative approach to abolish asynchrony is to use fast ventilator rates (60–120/min high-frequency positive pressure ventilation, HFPPV), which more closely reflects the infant's spontaneous respiratory rate; meta-analysis of the results of RCTs [25] show that HFPPV compared to slower rate PLV significantly reduces air leaks (RR, 0.69; 95% CI, 0.51–0.93), but only in prematurely born infants [9,11].
Pulmonary Outcome and Follow-Up
2011, Assisted Ventilation of the NeonateBacterial Infections of the Respiratory Tract
2011, Infectious Diseases of the Fetus and Newborn InfantPulmonary outcome and follow-up
2010, Assisted Ventilation of the Neonate: Expert Consult - Online and PrintBacterial infections of the respiratory tract
2010, Infectious Diseases of the Fetus and Newborn: Expert Consult - Online and PrintBacterial Infections of the Respiratory Tract
2006, Infectious Diseases of the Fetus and Newborn Infant
Copyright © 1998 Elsevier Ltd. All rights reserved.